EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance

[1]  W. Witte,et al.  Performance of three chromogenic VRE screening agars, two Etest(®) vancomycin protocols, and different microdilution methods in detecting vanB genotype Enterococcus faecium with varying vancomycin MICs. , 2012, Diagnostic microbiology and infectious disease.

[2]  G. Jacoby,et al.  vanM, a New Glycopeptide Resistance Gene Cluster Found in Enterococcus faecium , 2010, Antimicrobial Agents and Chemotherapy.

[3]  M. P. van der Linden,et al.  Penicillin-binding proteins in beta-lactam-resistant streptococcus pneumoniae. , 1999, Microbial drug resistance.

[4]  A. Sundsfjord,et al.  Evaluation of Rosco Neo‐Sensitabs for phenotypic detection and subgrouping of ESBL‐, AmpC‐ and carbapenemase‐producing Enterobacteriaceae , 2012, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[5]  C. Giske,et al.  Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae. , 2010, Journal of microbiological methods.

[6]  R. Leclercq,et al.  d-Ala-d-Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium , 2011, Antimicrobial Agents and Chemotherapy.

[7]  A. Sundsfjord,et al.  Performance of the EUCAST Disk Diffusion Method, the CLSI Agar Screen Method, and the Vitek 2 Automated Antimicrobial Susceptibility Testing System for Detection of Clinical Isolates of Enterococci with Low- and Medium-Level VanB-Type Vancomycin Resistance: a Multicenter Study , 2014, Journal of Clinical Microbiology.

[8]  George A. Jacoby,et al.  AmpC β-Lactamases , 2009, Clinical Microbiology Reviews.

[9]  L. Jetté,et al.  Use of an Oxacillin Disk Screening Test for Detection of Penicillin- and Ceftriaxone-Resistant Pneumococci , 1999, Journal of Clinical Microbiology.

[10]  N. Hanson,et al.  Detection of Plasmid-Mediated AmpC β-Lactamase Genes in Clinical Isolates by Using Multiplex PCR , 2002, Journal of Clinical Microbiology.

[11]  P. Ward,et al.  Improved Detection of vanB2-Containing Enterococcus faecium with Vancomycin Susceptibility by Etest Using Oxgall Supplementation , 2008, Journal of Clinical Microbiology.

[12]  P. Courvalin,et al.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR , 1995, Journal of clinical microbiology.

[13]  G. Trenholme,et al.  In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. , 1993, The Journal of infectious diseases.

[14]  Y. Arakawa,et al.  Practical Methods Using Boronic Acid Compounds for Identification of Class C β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli , 2005, Journal of Clinical Microbiology.

[15]  D. F. Sahm,et al.  AmpC beta-lactamases. , 1998 .

[16]  J. Mazuski.  Vancomycin-resistant enterococcus: risk factors, surveillance, infections, and treatment. , 2008, Surgical infections.

[17]  J. M. Dixon,et al.  Detection and prevalence of pneumococci with increased resistance to penicillin. , 1977, Canadian Medical Association journal.

[18]  A. Skotnicki,et al.  Selection of a Teicoplanin-Resistant Enterococcus faecium Mutant during an Outbreak Caused by Vancomycin-Resistant Enterococci with the VanB Phenotype , 2001, Journal of Clinical Microbiology.

[19]  G. Bou,et al.  Class C β-Lactamases: an increasing problem worldwide , 2004 .

[20]  F. Tenover,et al.  Vancomycin-resistant staphylococci and enterococci: epidemiology and control , 2005, Current opinion in infectious diseases.

[21]  L. Martínez-Martínez.  Extended-spectrum β-lactamases and the permeability barrier , 2008 .

[22]  R. Dagan.  Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[23]  I. Balakrishnan,et al.  An evaluation of the Mast D69C AmpC Detection Disc Set for the detection of inducible and derepressed AmpC β-lactamases. , 2012, The Journal of antimicrobial chemotherapy.

[24]  M. Mulvey,et al.  Molecular Characterization of Enterococcus faecalis N06-0364 with Low-Level Vancomycin Resistance Harboring a Novel d-Ala-d-Ser Gene Cluster, vanL , 2008, Antimicrobial Agents and Chemotherapy.

[25]  Samir N. Patel,et al.  Vancomycin-Variable Enterococci Can Give Rise to Constitutive Resistance during Antibiotic Therapy , 2014, Antimicrobial Agents and Chemotherapy.

[26]  R. Murray,et al.  Comparison of methods for AmpC β-lactamase detection in Enterobacteriaceae. , 2011, Journal of medical microbiology.

[27]  A. Sundsfjord,et al.  Heterogeneity in the vanB Gene Cluster of Genomically Diverse Clinical Strains of Vancomycin-Resistant Enterococci , 1999, Antimicrobial Agents and Chemotherapy.

[28]  K. Ramotar,et al.  Comparison of phenotypic methods to identify enterococci intrinsically resistant to vancomycin (VanC VRE). , 2000, Diagnostic microbiology and infectious disease.

[29]  P. Ingram,et al.  Low Vancomycin MICs and Fecal Densities Reduce the Sensitivity of Screening Methods for Vancomycin Resistance in Enterococci , 2014, Journal of Clinical Microbiology.

[30]  M. Weinstein,et al.  Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci , 1995, Journal of clinical microbiology.

[31]  T. Tan,et al.  Evaluation of Screening Methods To Detect Plasmid-Mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis , 2008, Antimicrobial Agents and Chemotherapy.

[32]  Robert A Bonomo,et al.  Identification of Plasmid-Mediated AmpC β-Lactamases in Escherichia coli, Klebsiella spp., and Proteus Species Can Potentially Improve Reporting of Cephalosporin Susceptibility Testing Results , 2008, Journal of Clinical Microbiology.

[33]  George A. Jacoby,et al.  Plasmid-Determined AmpC-Type β-Lactamases , 2002, Antimicrobial Agents and Chemotherapy.

[34]  C. Thornsberry,et al.  Screening pneumococci for penicillin resistance , 1986, Journal of clinical microbiology.

[35]  Ronald N. Jones,et al.  Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  P. Courvalin,et al.  Detection of the van Alphabet and Identification of Enterococci and Staphylococci at the Species Level by Multiplex PCR , 2004, Journal of Clinical Microbiology.

[37]  C. Giske,et al.  Phenotypic detection of plasmid-acquired AmpC in Escherichia coli—evaluation of screening criteria and performance of two commercial methods for the phenotypic confirmation of AmpC production , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[38]  U. Ullmann,et al.  A Novel Type of AmpC β-Lactamase, ACC-1, Produced by a Klebsiella pneumoniae Strain Causing Nosocomial Pneumonia , 1999, Antimicrobial Agents and Chemotherapy.

[39]  J. Hrabák,et al.  DHA-1-producing Klebsiella pneumoniae in a teaching hospital in the Czech Republic. , 2010, Microbial drug resistance.

[40]  Paul D. R. Johnson,et al.  Genomic analysis of teicoplanin resistance emerging during treatment of vanB vancomycin-resistant Enterococcus faecium infections in solid organ transplant recipients including donor-derived cases. , 2013, The Journal of antimicrobial chemotherapy.

[41]  Hubert P. Endtz,et al.  Comparison of Eight Methods To Detect Vancomycin Resistance in Enterococci , 1998, Journal of Clinical Microbiology.

[42]  H. Fang,et al.  Evaluation of species-specific PCR, Bruker MS, VITEK MS and the VITEK 2 system for the identification of clinical Enterococcus isolates , 2012, European Journal of Clinical Microbiology & Infectious Diseases.